Correlation of hair risperidone concentration and serum level among patients with schizophrenia
Background Risperidone (RSP) has a rapid onset in vivo, low dosage and high plasma protein binding rate, therefore therapeutic drug monitoring (TDM) is needed to ensure safety in clinical treatment. However, compared with blood, hair is non-invasive, safe, non-infectious and easy to transport and st...
Saved in:
| Main Authors: | Xiujia Sun, Lihua Wang, Fuzhong Yang, Juanjuan Ren, Ping Jiang, Hongmei Liu, Huafang Li, Chunbo Li, Chen Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-02-01
|
| Series: | General Psychiatry |
| Online Access: | https://gpsych.bmj.com/content/32/1/e100042.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiologically based pharmacokinetic modeling to predict the effect of risperidone on aripiprazole pharmacokinetics in subjects with different CYP2D6 genotypes and individuals with hepatic impairment
by: Fan Mou, et al.
Published: (2024-12-01) -
Activation of osteoblast ferroptosis by risperidone accelerates bone loss in mice models of schizophrenia
by: Hongyan Fan, et al.
Published: (2025-01-01) -
Risperidone accelerates bone loss in mice models of schizophrenia by inhibiting osteoblast autophagy
by: Zaihong Yang, et al.
Published: (2024-11-01) -
CORRELATION BETWEEN COGNITIVE FUNCTION AND SERUM LEVELS OF TUMOR NECROSIS ALPHA (TNF-α) IN SCHIZOPHRENIA
by: Eldi Sauma, et al.
Published: (2024-02-01) -
Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
by: Amilton Dos Santos-Júnior, et al.
Published: (2016-01-01)